[
    [
        {
            "time": "2020-11-24",
            "original_text": "白云山(600332.SH)拟使用募集资金约4.89亿元增资化学制药(珠海)公司以建设项目",
            "features": {
                "keywords": [
                    "白云山",
                    "增资",
                    "化学制药",
                    "珠海",
                    "项目"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "白云山(600332.SH)拟使用募集资金约4.89亿元增资化学制药(珠海)公司以建设项目",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-24",
            "original_text": "白云山(00874.HK)拟向化学制药(珠海)增资4.89亿元",
            "features": {
                "keywords": [
                    "白云山",
                    "增资",
                    "化学制药",
                    "珠海"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "白云山(00874.HK)拟向化学制药(珠海)增资4.89亿元",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-24",
            "original_text": "白云山：拟向全资孙公司化学制药公司增资4.89亿元用于其项目建设",
            "features": {
                "keywords": [
                    "白云山",
                    "增资",
                    "孙公司",
                    "化学制药",
                    "项目建设"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "白云山：拟向全资孙公司化学制药公司增资4.89亿元用于其项目建设",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-24",
            "original_text": "白云山：4.89亿元增资孙公司",
            "features": {
                "keywords": [
                    "白云山",
                    "增资",
                    "孙公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "白云山：4.89亿元增资孙公司",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-24",
            "original_text": "白云山(00874.HK)：高燕珠辞去股东代表监事职务 董监高成员变化",
            "features": {
                "keywords": [
                    "白云山",
                    "高燕珠",
                    "辞职",
                    "监事"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "白云山(00874.HK)：高燕珠辞去股东代表监事职务 董监高成员变化",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-11-24",
            "original_text": "白云山(600332.SH)拟以募集资金通过全资子公司向全资孙公司增资",
            "features": {
                "keywords": [
                    "白云山",
                    "募集资金",
                    "增资",
                    "全资子公司",
                    "全资孙公司"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "白云山(600332.SH)拟以募集资金通过全资子公司向全资孙公司增资",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-24",
            "original_text": "白云山：监事因达到法定退休年龄辞职 董监高成员变化",
            "features": {
                "keywords": [
                    "白云山",
                    "监事",
                    "辞职",
                    "法定退休年龄"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "白云山：监事因达到法定退休年龄辞职 董监高成员变化",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]